Stocks in Focus: MV Oil Trust (NYSE:MVO), InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), New York REIT, Inc. (NYSE:NYRT), Celldex Therapeutics, Inc. (NASDAQ:CLDX)

MV Oil Trust (NYSE:MVO) shares increased 5.48% in last trading session and ended the day at $9.51. MVO return on assets is 145.90%. MV Oil Trust (NYSE:MVO) quarterly performance is -23.85%. MV Oil Trust (NYSE:MVO) announced the Trust distribution of net profits for the second quarterly payment period ended June 30, 2015. Unitholders of record on July 16, 2015 will receive a distribution amounting to $2,300,000 or $0.20 per unit payable July 24, 2015.

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) shares moved down -6.72% in last trading session and ended the day at $14.01. NVIV return on assets is -155.50%. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) quarterly performance is 13.53%. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) announced a one-month post-implant update for the third study patient and a six-month post-implant update for the second study patient in the company’s ongoing pilot trial of its investigational Neuro-Spinal Scaffold in patients with complete acute spinal cord injury.

On 10 July, New York REIT, Inc. (NYSE:NYRT) shares moved up 1.39% and was closed at $10.19. NYRT EPS growth in last 5 year was -18.50%. New York REIT, Inc. (NYSE:NYRT) year to date (YTD) performance is -1.21%. New York REIT, Inc. (NYSE:NYRT) announced that, Distributions will be paid on a monthly basis to stockholders of record at the close of business on the eighth day of each month, payable on the 15th day of such month, in each case, unless such date is a non-business day. Accordingly, on July 15, 2015, August 14, 2015, and September 15, 2015, NYRT will pay a distribution of$0.038333333 per share to stockholders of record at the close of business on July 8, 2015, August 7, 2015, and September 8, 2015, respectively.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares increased 1.72% in last trading session and ended the day at $24.89. CLDX return on assets is -48.40%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) quarterly performance is -12.85%.On 1 July, Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced the promotion of Richard Wright, Ph.D. to Senior Vice President and the newly created position of Chief Commercial Officer. Dr. Wright was previously Vice President of Commercial Operations at Celldex and brings nearly 25 years of industry experience, including the commercialization of six successful drug therapies. As Chief Commercial Officer, Dr. Wright is responsible for developing global business strategy and building the infrastructure required to support commercialization of Celldex’s cancer immunotherapy pipeline.

Leave a Reply

Your email address will not be published. Required fields are marked *